Maternal Flu Vaccine Trial in Bamako, Mali

PHASE4CompletedINTERVENTIONAL
Enrollment

4,193

Participants

Timeline

Start Date

September 12, 2011

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Influenza
Interventions
BIOLOGICAL

Inactivated Influenza Vaccine Trivalent Types A and B

"Pregnant Woman: Randomization to receive IM injection of Vaxigrip Influenza Vaccine once~Household and Woman/Infant surveillance~* Home visits weekly until the infant is born and reaches 6 months of age~* If the woman, her infant or other household contact has signs and symptoms consistent with Influenza Like Illness (ILI)a nasal and oropharyngeal swab will be obtained"

BIOLOGICAL

Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate Vaccine

"Pregnant Women - Randomized to receive IM injection of Menactra once~Household and Woman/Infant surveillance~* Home visits weekly until the infant is born and reaches 6 months of age~* If the woman, her infant or other household contact has signs and symptoms consistent with Influenza Like Illness (ILI)a nasal and oropharyngeal swab will be obtained"

Trial Locations (1)

Unknown

Centre pour le Developpement des Vaccins - Mali, Bamako

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

lead

University of Maryland, Baltimore

OTHER

NCT01430689 - Maternal Flu Vaccine Trial in Bamako, Mali | Biotech Hunter | Biotech Hunter